Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Matthew Greenhawt to Administration, Oral

This is a "connection" page, showing publications Matthew Greenhawt has written about Administration, Oral.

 
Connection Strength
 
 
 
0.696
 
  1. Greenhawt M, Marsh R, Gilbert H, Sicherer S, DunnGalvin A, Matlock D. Understanding caregiver goals, benefits, and acceptable risks of peanut allergy therapies. Ann Allergy Asthma Immunol. 2018 11; 121(5):575-579.
    View in: PubMed
    Score: 0.131
  2. Greenhawt M, Hourihane JO. Looking into the seeds of time: Are home-based OIT programs the shape of things to come for selected patients? Ann Allergy Asthma Immunol. 2018 05; 120(5):453-454.
    View in: PubMed
    Score: 0.129
  3. Greenhawt MJ. Oral and sublingual peanut immunotherapy is not ready for general use. Allergy Asthma Proc. 2013 May-Jun; 34(3):197-204.
    View in: PubMed
    Score: 0.091
  4. Traister RS, Green TD, Mitchell L, Greenhawt M. Community opinions regarding oral immunotherapy for food allergies. Ann Allergy Asthma Immunol. 2012 Nov; 109(5):319-23.
    View in: PubMed
    Score: 0.088
  5. Anagnostou A, Greenhawt M, Rodriguez Del R?o P, Pickett G, Szafron V, Stukus D, Abrams EM. Addressing common questions on food oral immunotherapy: a practical guide for paediatricians. Arch Dis Child. 2024 08 16; 109(9):697-701.
    View in: PubMed
    Score: 0.050
  6. Mack DP, Greenhawt M, Anagnostou A. Are There Hidden Dangers Associated With Milk and Egg Dietary Advancement Therapy? J Allergy Clin Immunol Pract. 2023 04; 11(4):1056-1062.
    View in: PubMed
    Score: 0.045
  7. Mack DP, Greenhawt M, Turner PJ, Wasserman RL, Hanna MA, Shaker M, Hughes SW, Del R?o PR. Information needs of patients considering oral immunotherapy for food allergy. Clin Exp Allergy. 2022 12; 52(12):1391-1402.
    View in: PubMed
    Score: 0.044
  8. Chua GT, Greenhawt M, Shaker M, Soller L, Abrams EM, Cameron SB, Cook VE, Erdle SC, Fleischer DM, Mak R, Vander Leek TK, Chan ES. The Case for Prompt Salvage Infant Peanut Oral Immunotherapy Following Failed Primary Prevention. J Allergy Clin Immunol Pract. 2022 10; 10(10):2561-2569.
    View in: PubMed
    Score: 0.043
  9. Wasserman RL, Factor J, Windom HH, Abrams EM, Begin P, Chan ES, Greenhawt M, Hare N, Mack DP, Mansfield L, Ben-Shoshan M, Stukus DR, Leek TV, Shaker M. An Approach to the Office-Based Practice of Food Oral Immunotherapy. J Allergy Clin Immunol Pract. 2021 05; 9(5):1826-1838.e8.
    View in: PubMed
    Score: 0.039
  10. Westerhout J, Baumert JL, Blom WM, Allen KJ, Ballmer-Weber B, Crevel RWR, Dubois AEJ, Fern?ndez-Rivas M, Greenhawt MJ, Hourihane JO, Koplin JJ, Kruizinga AG, Le TM, Sampson HA, Shreffler WG, Turner PJ, Taylor SL, Houben GF, Remington BC. Deriving individual threshold doses from clinical food challenge data for population risk assessment of food allergens. J Allergy Clin Immunol. 2019 11; 144(5):1290-1309.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)